Despite the cellular adaptation, SCR‐7952 exhibited promising antiproliferative activity on MTAP‐deleted cancer cells, more potent and selective than AG‐270, which was presumably a result of its high enzyme activity. This evidence concerns the gene MTAP and cancer.